HANOI, May 4 (Xinhua) -- Vietnam spent 801 million U.S. dollars importing evidence-based medicines from January to April, seeing a year-on-year decline of 2.9 percent, according to the country's General Statistics Office on Thursday.
Vietnam's medicine import turnovers were over 2.8 billion U.S. dollars last year, mainly coming from France, India, Germany, South Korea, the United States, Britain, Italy, Switzerland, Belgium and Thailand.
According to global research firm BMI Research, Vietnams pharmaceutical market in 2017 grew some 10 percent against 2016 to 5.2 billion U.S. dollars, and it would continue to grow at a double-digit rate in the next five years.
On average, one Vietnamese person's annual spending on pharmaceutical products rose to 37.97 U.S. dollars in 2015 from 22.25 U.S. dollars in 2010 and 9.85 U.S. dollars in 2005, said a local ratings company named Vietnam Report.
The spending will surge to 85 U.S. dollars by 2020 and 163 U.S. dollars by 2025, the Vietnamese company predicted.
A single purchase
